Released from intestinal K cells after a meal, GIP acts on the beta cell to enhance glucose-dependent insulin secretion, and it has receptors in adipose tissue and in the brain. Its insulinotropic effect is blunted in type 2 diabetes, which for a long time made it the less attractive incretin to pursue.
The discovery that dual GIP and GLP-1 receptor agonism outperformed GLP-1 agonism alone revived interest, and retatrutide builds on that.
Both activating and blocking the GIP receptor have reduced weight in rodent models, a finding reported by independent groups and not fully resolved. Proposed explanations include receptor desensitisation under sustained agonism and species differences.
A page that presents GIP's weight role as settled is simplifying a literature that is not. The honest summary is that GIP receptor agonism in combination with GLP-1 receptor agonism reduces weight in people, as the trials show, and that the mechanism is still being worked out.
The molecule was engineered from a GIP-based sequence, with substitutions adding GLP-1 and glucagon activity. That origin is why its GIP receptor potency is high relative to the other two, and it is reported in the 2022 characterisation.
The backbone is a chemistry fact about this molecule; the weight mechanism is a biology question about the receptor. They are separate.
Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.
| Format | Strength | Price | Availability |
|---|---|---|---|
| Retatrutide Pack | 20 mg | AED 1010 | In stock |
Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.
Released from intestinal K cells after a meal, GIP acts on the beta cell to enhance glucose-dependent insulin secretion, and it has receptors in adipose tissue and in the brain. Its insulinotropic effect is blunted in type 2 diabetes, which for a long time made it the less attractive incretin to pursue.
No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.
Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.
Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.